Barbara Rellahan

Lessons Learned from Monoclonal Antibody Applications to the Office of Biotechnology Products Quality by Design Pilot Program

Barbara Rellahan, Steven Kozlowski, Patrick Swann, 2015 .

Expectations for Phase-Appropriate Drug Substance and Drug Product Specifications for Early-Stage Protein Therapeutics.

Barbara Rellahan, Ping Yin, Juliana Kretsinger, 2019, Journal of pharmaceutical sciences.

Strategies for Setting Patient-Centric Commercial Specifications for Biotherapeutic Products.

Barbara Rellahan, Luca Benetti, Ping Yin, 2020, Journal of pharmaceutical sciences.

QbD for Biologics Learning from the Product Development and Realization ( A-MAb ) Case Study and the FDA OBP Pilot Program

Barbara Rellahan, Victor Vinci, Lorna McLeod, 2015 .